LoJaimiess

Xiromed, LLC.🇺🇸 United States

FDA Page

Effective Date: Feb 25, 2023
Approval ID: 5f0b397c-256a-0163-35c7-e9401705b439
Products: 1 registered
Version: 8

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use LoJaimiess safely and effectively. See full prescribing information for LoJaimiess. LoJaimiess® Levonorgestrel and Ethinyl Estradiol Tablets,USP and Ethinyl Estradiol Tablets, USP 0.1 mg/0.02 mg, and 0.01 mg for oral use Initial U.S. Approval: 1982

Quick Stats

Total Products1

Labelers2

Label Sections19

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.